Lars Noah




Mailing Address:
Box #117625 Gainesville, FL 32611





J.D., Harvard University (magna cum laude) B.A., Harvard University (magna cum laude)

Teaching & Scholarship

Medical Technology, Torts, Products Liability, Administrative Law

Professional Activities

  • University of Florida: Joined College of Law faculty in 1994; Teacher of the Year (1995, 1998 & 2004)
  • Visiting Faculty: Georgetown University, George Washington University, University of Texas, University of California (Hastings), Vanderbilt University, Washington & Lee University.
  • Consultant: Institute of Medicine (dietary supplements, 2001; dioxins, 2003; food safety, 2009); National Institutes of Health (medical device retrieval, 2000); U.S. House Judiciary Committee (FCC merger approvals, 1999); U.S. Senate Judiciary Committee (tobacco legislation, 1997-98); Food and Drug Administration (nonprescription drug labeling, 1995).

Torts (4 credits) - LAW 5700

  • Civil liability for harm caused by wrongful acts that violate non-contractual duties imposed by law. Covers negligence and other theories of liability as prescribed by the instructor.

Medical Technology and the Law (2 or 3 credits) - LAW 6930

  • This course considers the many ways our society manages medical technologies (primarily pharmaceuticals and medical devices), including direct federal regulation of research, development and marketing; products liability doctrines affecting manufacturing, design, and labeling; and the impacts of insurance systems and intellectual property regimes on access and innovation.

Products Liability (2 credits) - LAW 6702

  • An advanced torts offering that focuses on the special rules applicable to sellers and other distributors of consumer goods and similar items, covering defects in manufacturing, design, and labeling--whether framed in terms of negligence, strict liability, or breach of warranty--as well as collateral issues such as product misuse, subsequent modification, and federal preemption.

Current Books


Selected Articles

  • Turn the Beat Around?: Deactivating Implanted Cardiac-Assist Devices, 39 William Mitchell Law Review 1229 (2013).
  • Truth or Consequences?: Commercial Free Speech vs. Public Health Promotion (at the FDA), 21 Health Matrix 31 (2011).
  • Coerced Participation in Clinical Trials: Conscripting Human Research Subjects, 62 Administrative Law Review 329 (2010).
  • Comfortably Numb: Medicalizing (and Mitigating) Pain-and-Suffering Damages, 42 University of Michigan Journal of Law Reform 431 (2009).
  • This Is Your Products Liability Restatement on Drugs, 74 Brooklyn Law Review 839 (2009).
  • The Little Agency That Could (Act with Indifference to Constitutional and Statutory Strictures), 93 Cornell Law Review 901 (2008).
  • Too High a Price for Some Drugs?: The FDA Burdens Reproductive Choice, 44 San Diego Law Review 231 (2007).
  • Treat Yourself: Is Self-Medication the Prescription for What Ails American Health Care?, 19 Harvard Journal of Law & Technology 359 (2006).
  • Managing Biotechnology’s Revolution: Has Guarded Enthusiasm Become Benign Neglect?, 11 Virginia Journal of Law & Technology 4 (2006).
  • An Inventory of Mathematical Blunders in Applying the Loss-of-a-Chance Doctrine, 24 Review of Litigation 369 (2005).
  • Ambivalent Commitments to Federalism in Controlling the Practice of Medicine, 53 University of Kansas Law Review 149 (2004).
  • A Postmodernist Take on the Human Embryo Research Debate, 36 Connecticut Law Review 1133 (2004).
  • Deputizing Institutional Review Boards to Police (Audit?) Biomedical Research, 25 Journal of Legal Medicine 267 (2004).
  • Assisted Reproductive Technologies and the Pitfalls of Unregulated Biomedical Innovation, 55 Florida Law Review 603 (2003).
  • Challenges in the Federal Regulation of Pain Management Technologies, 31 Journal of Law, Medicine & Ethics 55 (2003).
  • Triage in the Nation's Medicine Cabinet: The Puzzling Scarcity of Vaccines and Other Drugs, 54 South Carolina Law Review 741 (2003).
  • The Coming Pharmacogenomics Revolution: Tailoring Drugs to Fit Patients' Genetic Profiles, 43 Jurimetrics Journal 1 (2002).
  • Informed Consent and the Elusive Dichotomy Between Standard and Experimental Therapy, 28 American Journal of Law & Medicine 361 (2002).
  • Medicine's Epistemology: Mapping the Haphazard Diffusion of Knowledge in the Biomedical Community, 44 Arizona Law Review 373 (2002).
  • Civil Jury Nullification, 86 Iowa Law Review 1601 (2001).
  • Rewarding Regulatory Compliance: The Pursuit of Symmetry in Products Liability, 88 Georgetown Law Journal 2147 (2000).
  • Interpreting Agency Enabling Acts: Misplaced Metaphors in Administrative Law, 41 William & Mary Law Review 1463 (2000).
  • Scientific "Republicanism": Expert Peer Review and the Quest for Regulatory Deliberation, 49 Emory Law Journal 1033 (2000).
  • Pigeonholing Illness: Medical Diagnosis as a Legal Construct, 50 Hastings Law Journal 241 (1999).